The Platelet-to-Lymphocyte Ratio captures thromboinflammatory state and adaptive immune suppression simultaneously.
The Platelet-to-Lymphocyte Ratio captures thromboinflammatory state and adaptive immune suppression simultaneously. It is a validated poor-prognosis marker in oncology, cardiovascular disease, and autoimmune conditions.
Chronic inflammation, iron deficiency (reactive thrombocytosis), autoimmune disease, malignancy, hepatic disease. Splenomegaly reduces platelets and elevates PLR.
Asymptomatic. Extreme platelet elevation may present with easy bruising, petechiae, or thrombotic events.
See NLR. Omega-3 reduces platelet aggregation. Regular aerobic exercise normalises platelet reactivity and supports lymphocyte counts.
See NLR. Ultra-processed foods sustain the chronic-inflammation pattern that drives PLR elevation.
Educational information only — not a diagnosis. Every Pheno result is interpreted in context and reviewed by a physician.
See all 119 markers we test →